InvestSMART

4DMedical Limited (ASX:4DX)

ALERT: Price-sensitive ASX Announcement for 4DX
Current share price for 4DX : $3.640 -0.27 (-6.91%)+
Announcement
Release
16 Jul 2026 10:45AM
Price at Release
$3.910
Full Release
download
Summary
4DMedical Limited (ASX: 4DX) requested a trading halt on its securities from the Australian Securities Exchange (ASX), as per ASX Listing Rule 17.1, effective from the commencement of trading on 16 July 2026. This trading halt was sought in anticipation of an upcoming company announcement concerning potential implications from a bill proposed in the US Congress. The halt is intended to assist 4DMedical in managing its continuous disclosure obligations and will remain in place until the earlier of the commencement of normal trading on 17 July 2026 or the release of the relevant announcement. The company expects to make this announcement before trading resumes on 17 July 2026. 4DMedical confirmed there were no reasons the halt should not be granted and no further information was necessary for the market.
Key Points
  • 4DMedical Limited requested a trading halt on ASX.
  • The halt is pending an announcement regarding a US Congress bill.
  • Trading halt effective from 16 July 2026 until 17 July 2026 or announcement.
  • The halt assists in managing continuous disclosure obligations.
  • Company expects to announce before 17 July 2026 trading resumption.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.